M Brandon Westover1, Mouhsin M Shafi2, Matt T Bianchi3, Lidia M V R Moura4, Deirdre O'Rourke5, Eric S Rosenthal6, Catherine J Chu7, Samantha Donovan8, Daniel B Hoch9, Ronan D Kilbride10, Andrew J Cole11, Sydney S Cash12. 1. Department of Neurology, Epilepsy Service, Massachusetts General Hospital, Wang 720, Boston, MA 02114, USA. Electronic address: mwestover@mgh.harvard.edu. 2. Department of Neurology, Epilepsy Service, Massachusetts General Hospital, Wang 720, Boston, MA 02114, USA; Department of Neurology, Epilepsy Service, Beth Israel Deaconess Medical Center, West/Baker 5, Boston, MA 02214, USA. Electronic address: mshafi@bidmc.harvard.edu. 3. Department of Neurology, Epilepsy Service, Massachusetts General Hospital, Wang 720, Boston, MA 02114, USA. Electronic address: mtbianchi@mgh.harvard.edu. 4. Department of Neurology, Epilepsy Service, Massachusetts General Hospital, Wang 720, Boston, MA 02114, USA. Electronic address: lmoura@mgh.harvard.edu. 5. Department of Neurology, Epilepsy Service, Massachusetts General Hospital, Wang 720, Boston, MA 02114, USA. Electronic address: daorourke@mgh.harvard.edu. 6. Department of Neurology, Epilepsy Service, Massachusetts General Hospital, Wang 720, Boston, MA 02114, USA. Electronic address: erosenthal@mgh.harvard.edu. 7. Department of Neurology, Epilepsy Service, Massachusetts General Hospital, Wang 720, Boston, MA 02114, USA. Electronic address: cchu3@mgh.harvard.edu. 8. Department of Neurology, Epilepsy Service, Massachusetts General Hospital, Wang 720, Boston, MA 02114, USA. 9. Department of Neurology, Epilepsy Service, Massachusetts General Hospital, Wang 720, Boston, MA 02114, USA. Electronic address: dbhoch@mgh.harvard.edu. 10. Department of Neurology, Epilepsy Service, Massachusetts General Hospital, Wang 720, Boston, MA 02114, USA. Electronic address: rkilbride@mgh.harvard.edu. 11. Department of Neurology, Epilepsy Service, Massachusetts General Hospital, Wang 720, Boston, MA 02114, USA. Electronic address: acole1@mgh.harvard.edu. 12. Department of Neurology, Epilepsy Service, Massachusetts General Hospital, Wang 720, Boston, MA 02114, USA. Electronic address: scash@mgh.harvard.edu.
Abstract
OBJECTIVE: To characterize the risk for seizures over time in relation to EEG findings in hospitalized adults undergoing continuous EEG monitoring (cEEG). METHODS: Retrospective analysis of cEEG data and medical records from 625 consecutive adult inpatients monitored at a tertiary medical center. Using survival analysis methods, we estimated the time-dependent probability that a seizure will occur within the next 72-h, if no seizure has occurred yet, as a function of EEG abnormalities detected so far. RESULTS: Seizures occurred in 27% (168/625). The first seizure occurred early (<30min of monitoring) in 58% (98/168). In 527 patients without early seizures, 159 (30%) had early epileptiform abnormalities, versus 368 (70%) without. Seizures were eventually detected in 25% of patients with early epileptiform discharges, versus 8% without early discharges. The 72-h risk of seizures declined below 5% if no epileptiform abnormalities were present in the first two hours, whereas 16h of monitoring were required when epileptiform discharges were present. 20% (74/388) of patients without early epileptiform abnormalities later developed them; 23% (17/74) of these ultimately had seizures. Only 4% (12/294) experienced a seizure without preceding epileptiform abnormalities. CONCLUSIONS: Seizure risk in acute neurological illness decays rapidly, at a rate dependent on abnormalities detected early during monitoring. This study demonstrates that substantial risk stratification is possible based on early EEG abnormalities. SIGNIFICANCE: These findings have implications for patient-specific determination of the required duration of cEEG monitoring in hospitalized patients.
OBJECTIVE: To characterize the risk for seizures over time in relation to EEG findings in hospitalized adults undergoing continuous EEG monitoring (cEEG). METHODS: Retrospective analysis of cEEG data and medical records from 625 consecutive adult inpatients monitored at a tertiary medical center. Using survival analysis methods, we estimated the time-dependent probability that a seizure will occur within the next 72-h, if no seizure has occurred yet, as a function of EEG abnormalities detected so far. RESULTS:Seizures occurred in 27% (168/625). The first seizure occurred early (<30min of monitoring) in 58% (98/168). In 527 patients without early seizures, 159 (30%) had early epileptiform abnormalities, versus 368 (70%) without. Seizures were eventually detected in 25% of patients with early epileptiform discharges, versus 8% without early discharges. The 72-h risk of seizures declined below 5% if no epileptiform abnormalities were present in the first two hours, whereas 16h of monitoring were required when epileptiform discharges were present. 20% (74/388) of patients without early epileptiform abnormalities later developed them; 23% (17/74) of these ultimately had seizures. Only 4% (12/294) experienced a seizure without preceding epileptiform abnormalities. CONCLUSIONS:Seizure risk in acute neurological illness decays rapidly, at a rate dependent on abnormalities detected early during monitoring. This study demonstrates that substantial risk stratification is possible based on early EEG abnormalities. SIGNIFICANCE: These findings have implications for patient-specific determination of the required duration of cEEG monitoring in hospitalized patients.
Authors: Lidia M V R Moura; Thiago S Carneiro; David Kwasnik; Valdery F Moura; Christine S Blodgett; Joseph Cohen; Mary McKenna Guanci; Daniel B Hoch; John Hsu; Andrew J Cole; M Brandon Westover Journal: Neurol Clin Pract Date: 2017-02
Authors: Carla Bentes; Hugo Martins; Ana Rita Peralta; Carlos Casimiro; Carlos Morgado; Ana Catarina Franco; Ana Catarina Fonseca; Ruth Geraldes; Patrícia Canhão; Teresa Pinho E Melo; Teresa Paiva; José M Ferro Journal: J Neurol Date: 2017-08-14 Impact factor: 4.849
Authors: Susan T Herman; Nicholas S Abend; Thomas P Bleck; Kevin E Chapman; Frank W Drislane; Ronald G Emerson; Elizabeth E Gerard; Cecil D Hahn; Aatif M Husain; Peter W Kaplan; Suzette M LaRoche; Marc R Nuwer; Mark Quigg; James J Riviello; Sarah E Schmitt; Liberty A Simmons; Tammy N Tsuchida; Lawrence J Hirsch Journal: J Clin Neurophysiol Date: 2015-04 Impact factor: 2.177
Authors: Aaron F Struck; Mohammad Tabaeizadeh; Sarah E Schmitt; Andres Rodriguez Ruiz; Christa B Swisher; Thanujaa Subramaniam; Christian Hernandez; Safa Kaleem; Hiba A Haider; Abbas Fodé Cissé; Monica B Dhakar; Lawrence J Hirsch; Eric S Rosenthal; Sahar F Zafar; Nicholas Gaspard; M Brandon Westover Journal: JAMA Neurol Date: 2020-04-01 Impact factor: 18.302
Authors: Jin Jing; Haoqi Sun; Jennifer A Kim; Aline Herlopian; Ioannis Karakis; Marcus Ng; Jonathan J Halford; Douglas Maus; Fonda Chan; Marjan Dolatshahi; Carlos Muniz; Catherine Chu; Valeria Sacca; Jay Pathmanathan; Wendong Ge; Justin Dauwels; Alice Lam; Andrew J Cole; Sydney S Cash; M Brandon Westover Journal: JAMA Neurol Date: 2020-01-01 Impact factor: 18.302
Authors: Jennifer A Kim; Emily J Boyle; Alexander C Wu; Andrew J Cole; Kevin J Staley; Sahar Zafar; Sydney S Cash; M Brandon Westover Journal: Ann Neurol Date: 2018-04-10 Impact factor: 10.422
Authors: J A Kim; E S Rosenthal; S Biswal; S Zafar; A V Shenoy; K L O'Connor; S C Bechek; J Valdery Moura; M M Shafi; A B Patel; S S Cash; M B Westover Journal: Clin Neurophysiol Date: 2017-01-29 Impact factor: 3.708
Authors: Lila T Worden; Dhinakaran M Chinappen; Sally M Stoyell; Jacquelyn Gold; Luis Paixao; Kalpathy Krishnamoorthy; Mark A Kramer; Michael B Westover; Catherine J Chu Journal: Epilepsia Date: 2019-11-19 Impact factor: 5.864